Loading
Search
▼ FOCUS: Bidding War May Break Out For Toshiba, More Business Reform Likely
- Category:Other
With a recent buyout offer for Toshiba Corp. from a British private equity firm apparently hitting a snag, a bidding war involving other investors may break out for the Japanese industrial conglomerate, industry experts say.
Investor interest in the growth potential of some of Toshiba's businesses, such as chip-making and infrastructure systems, means the company is likely to face continued pressure to streamline its wide-ranging operations, they say.
Toshiba's management rift widened after CVC Capital Partners made a buyout offer worth over $20 billion, leading its board members to believe the former president and CEO Nobuaki Kurumatani, once a CVC executive, was pulling strings to fend off pressure from activist shareholders.
Toshiba said Wednesday Kurumatani, who has led the company since 2018, offered to resign. He said in a statement he wants to take some time for himself after achieving the company's turnaround without making any reference to the CVC proposal.
Osamu Nagayama, chairman of Toshiba's board, confronted Kurumatani in the boardroom and expressed displeasure with CVC's buyout offer, sources with knowledge of the matter have said.
Nagayama and some other board members are believed to have raised questions about Kurumatani's stance of preventing activist shareholders from wielding influence.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.
Aiming to block CVC's acquisition plans and keep Toshiba listed on the Tokyo bourse, the conglomerate's executives asked creditor banks not to fund the private equity firm's buyout, according to people close to the matter.
CVC had previously planned to submit a detailed proposal in 10 days after sending its initial plan to Toshiba on April 6, while seeking cooperation from the Development Bank of Japan and Japan Investment Corp., a private-public sector fund, other sources have said.
But CVC did not deliver the formal offer by Friday, as it was seemingly monitoring the situation after Kurumatani's resignation with the possibility of launching a hostile takeover bid.
American global investment firm Kohlberg Kravis Roberts & Co. and Canadian investment giant Brookfield Asset Management Inc. reportedly plan to submit buyout proposals of their own.
"Investors are interested in Toshiba's chip-making affiliate Kioxia Holdings Corp.," possibly outbidding CVC, SBI Securities Co.'s senior analyst Yoshiharu Izumi said.
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
A global shortage of semiconductors due to robust demand for automobiles, smartphones and other electronic devices has spotlighted chipmakers.
Toshiba owns a 40.64 percent stake in Kioxia, into which the Japanese firm spun off its chip business after selling a majority stake to a consortium led by U.S. private equity firm Bain Capital in 2018. Toshiba plans to list Kioxia and use a large part of the proceeds to increase shareholder returns.
Tatsuo Ushijima, a professor specializing in corporate strategy at Keio University, said going private makes sense for Toshiba to further reform its group operations.
"Toshiba would need to review its wide-ranging businesses (from nuclear power to home lighting equipment) in an environment with fewer investors holding its shares," Ushijima said.
"Toshiba must at first outline its growth strategy regardless of whether it is going it alone or working with partners."
- April 17, 2021
- Comment (1217)
- Trackback(0)
Comment(s) Write comment
order generic cialis by phone <a href="https://qcialiuss.com/ ">where to buy cialis in canada</a> tadalafil powder bulk https://qcialiuss.com/
-
Jrnogaima Web Site
- August 12, 2022
Isoptin SR <a href="https://upharmu.com/ ">Kamagra</a> Pamelor
-
Egwsaisa Web Site
- August 11, 2022
cialis coupon code <a href="https://formenciales.com/ ">cialis 20 mg duration</a> cialis marke 20mg
-
AfgoAmows Web Site
- August 10, 2022
Betapace <a href="https://zpharz.com/ ">Tetracycline</a> Voveran
-
Nrfxgaima Web Site
- August 10, 2022
sildenafil 100 no prescription <a href="https://seinviagro.com/ ">viagra 100mg cost canada</a> can you order viagra without a prescription
-
Jrvxgaima Web Site
- August 9, 2022
arthritis plaquenil [url=https://plaquenilus.com/#]hydroxychloroquine drug [/url] what class of drugs is plaquenil what testing are required for plaquenil
-
nolvadex buy uk Web Site
- August 9, 2022
Effexor <a href="https://zpharz.com/ ">Flomax</a> Lotrisone
-
Nrfxgaima Web Site
- August 8, 2022
get viagra prescription online <a href="https://liviagrdo.com/ ">pharmacy viagra</a> discount online viagra
-
WrfvBries Web Site
- August 8, 2022
how to get female viagra pill <a href="https://liviagrdo.com/ ">viagra cream online</a> best price genuine viagra
-
WrfvBries Web Site
- August 8, 2022
whats better cialis or viagra <a href="https://tocialius.com/ ">black cialis mexico</a> how many years can you take cialis?
-
JunbNulajagma Web Site
- August 8, 2022
cialis from usa <a href="https://formenciales.com/ ">where can i get cialis</a> cialis 30 mg dose
-
AfgoAmows Web Site
- August 7, 2022
Uroxatral <a href="https://upharmu.com/ ">Eldepryl</a> Geodon
-
Egwsaisa Web Site
- August 7, 2022
levothyroxine pills <a href="https://synthroidus.com/#">cost of generic synthroid </a> how to take synthroid medication what is levothyroxine made of
-
buy cheap valtrex Web Site
- August 7, 2022
amoxicillin chemical structure [url=http://amoxilus.com/#]how to get amoxicillin [/url] amoxil for 18 pounds baby what is the dosage of amoxil
-
valtrex drugstore Web Site
- August 6, 2022
JxedNulajagma Web Site- August 12, 2022